Licheng Wang | Urology | Best Researcher Award

Published on by Global Academic Awards

Dr. Licheng Wang | Urology | Best Researcher Award

Dr. Licheng Wang, Shanghai Tongji Hospital, China

Dr. Licheng Wang (born October 16, 1992) is a urologist and research scientist at Shanghai Tongji Hospital 🎓. He holds a doctorate in urology and specializes in prostate cancer research, focusing on DNA damage repair, PSMA-targeted therapies, and drug resistance using single-cell and multi-omics analysis 🔬🧬. As a first or corresponding author, he has published in top-tier journals like Int J Biol Macromol, Current Oncology Reports, and Frontiers in Immunology 📚. Dr. Wang presented his work on SUMOylation and telomere biology at the 2021 Cold Spring Harbor meeting 🎤, emphasizing genomic stability in cancer

Publication Profile

Scopus

Academic Background

Dr. Licheng Wang (born October 16, 1992) is a dedicated urologist and researcher at Shanghai Tongji Hospital. 🎓 He holds a doctorate in Urology and specializes in prostate cancer research, focusing on 🔬 DNA damage repair mechanisms, PSMA-targeted therapies, and single-cell multi-omics of drug resistance. 📚 Dr. Wang has published several high-impact Q1 papers as first and corresponding author and has presented at leading conferences like Cold Spring Harbor. 🧬 His work contributes significantly to understanding and overcoming treatment resistance in castration-resistant prostate cancer (CRPC).

Academic Engagement

Dr. Licheng Wang is an accomplished urologist and cancer researcher at Shanghai Tongji Hospital. 🎓 Holding a doctorate in Urology, his work delves into 🔬 prostate cancer mechanisms, especially DNA repair, drug resistance, and PSMA-targeted therapies. 🧬 He actively engages in academic discourse, presenting cutting-edge findings at top-tier events, including a notable talk at the 2021 Cold Spring Harbor conference on SUMOylation and telomere biology—key to understanding genomic stability. 📚 With several Q1 publications as first or corresponding author, Dr. Wang is shaping future cancer treatments.

Research focus

Dr. Licheng Wang’s research focus lies in advanced prostate cancer biology and therapeutic innovation. His work primarily targets 🔁 drug resistance mechanisms, particularly in castration-resistant prostate cancer (CRPC) through metabolic and lncRNA pathways. 🧬 He explores the role of immune microenvironment and immune-related subtypes, providing insights into personalized cancer treatment. 🧠 Using cutting-edge imaging like PSMA-PET/CT, his research aids in accurate diagnosis and therapy redirection. 🧫 By combining molecular biology, multi-omics, and translational oncology, Dr. Wang contributes significantly to cancer prognosis, resistance profiling, and targeted therapies—making his research impactful in cancer genomics and clinical urology

Conclusion

Dr. Licheng Wang’s strong academic profile, impactful research publications, leadership roles in authorship, and active international engagement, he is an excellent candidate for the Best Researcher Award in Urology or Medical Research. His work is both innovative and clinically relevant, contributing meaningfully to the future of prostate cancer management.

Publication Top Notes

  • 📄 2024 – Glycolysis-related lncRNA SNHG3/miR-139-5p/PKM2 axis promotes CRPC development and enzalutamide resistance – Co-corresponding Author, Int J Biol Macromol, Cited by: [Awaiting citations, newly published] 🔬

  • 📄 2025 – The Evolving Role of PSMA-PET/CT in Prostate Cancer Management – First Author, Current Oncology Reports, Cited by: [Forthcoming, early release] 🧠

  • 📄 2022 – Immune microenvironment infiltration and immune-related subtypes in prostate cancer – Corresponding Author, Front Immunol, Cited by: 45+ 🧬

Esther Garcia Rojo | Urology | Young Scientist Award

Published on by Global Academic Awards

Mrs.Esther Garcia Rojo |  Urology | Young Scientist Award

PhD at Hm Sanchinarro, Spain

👩‍⚕️ Dr. Esther Garcia Rojo is a distinguished Urologist based in Madrid, Spain, affiliated with HM Hospitales and ROC Clinic. She specializes in Uro-Oncology and Andrology, serving as the Clinical Trials Coordinator in the Urology Department at HM Hospitales. With a medical degree from the University of Medicine, Valladolid, she completed her Urology residency at the University Hospital 12 de Octubre, Madrid. Dr. Garcia Rojo is a dedicated researcher, currently pursuing a PhD at Universidad Camilo Jose Cela. She is a Board Member of the European Association of Urology and actively contributes to the ESSM Scientific Committee. Additionally, she is the visionary behind the Urology Cheat Sheets and Urology 3D projects, showcasing her commitment to advancing urological knowledge. 🌐🔬

Publication Profile :

Scopus

Education :

🎓 Dr. Esther Garcia Rojo’s academic journey is marked by excellence and dedication. Graduating with a Bachelor of Medicine from the University of Medicine, Valladolid, Spain, between 2008 and 2014, she laid the foundation for her medical expertise. Subsequently, she pursued a Residency in Urology from 2015 to 2020 at the prestigious University Hospital 12 de Octubre in Madrid, refining her skills in urological care. Driven by a passion for advancing knowledge, since 2023, she has embarked on a challenging yet rewarding path as a PhD student at Universidad Camilo Jose Cela. This relentless pursuit of academic and professional growth solidifies her commitment to pushing the boundaries of urological research and patient care. 🏥📚

Courses, Masters Degree :

📚 Dr. Esther Garcia Rojo’s commitment to lifelong learning and specialization is evident through her extensive pursuit of courses and master’s degrees. In 2015, she delved into the “Methodological bases of biomedical research,” accumulating 70 hours of valuable insights. The year 2016 saw her achieve a Master’s degree in Clinical Medicine from UCJC, amassing 120 ECTS and further enriching her medical expertise. Driven by a quest for comprehensive skills, she completed courses in data management, basic statistics with SPSS, and ultrasounds in subsequent years. Notably, she explored the artistic dimension of urology at the EAU in Barcelona in 2018. Her mastery extended to advanced minimally invasive surgery, pelvic surgery, and assisted reproduction, demonstrating her dedication to the forefront of medical knowledge. Successfully passing the European Board of Urology exam in 2020, she culminated her academic journey with a Master’s Degree in Assisted Reproduction and Male Infertility from the University of Salamanca. Embracing cutting-edge technology, she undertook Da Vinci Technology Training in 2021 as a First Assistant, solidifying her position at the forefront of urological innovation. 🎓🔬

Teaching activity:

👩‍🏫 Dr. Esther Garcia Rojo is a dedicated educator, imparting her profound expertise in urology to aspiring medical professionals. Since 2021, she serves as a teacher in the Master’s Degree in Continuing Education in Andrology and Reconstructive Surgery of the Male Genital Area at the Universidad de Salamanca, contributing to the academic growth of future specialists. Previously, from 2015 to 2020, she played a vital role in the Department of Surgery at the Complutense University of Medicine (UCM), where her teaching extended to a comprehensive “Urology Update for General Doctors” course in 2018. Dr. Garcia Rojo’s passion for education seamlessly complements her clinical expertise, fostering the development of well-rounded healthcare professionals. 🎓🏥

Research Focus :

🔬 Dr. Esther Garcia Rojo is a distinguished Urologist with a research focus spanning diverse areas of urology and related fields. Her recent work includes a groundbreaking study on the detection rate of clinically significant prostate cancer, utilizing microultrasound-guided biopsy. She has contributed significantly to understanding the challenges and opportunities of social media interventions in urology, as well as exploring the diagnosis and treatment of cystic renal lesions. Additionally, her research extends to the functional role of STIM-1 and Orai1 in human microvascular aging. Dr. Garcia Rojo’s diverse and impactful contributions showcase her commitment to advancing knowledge in urology and related medical disciplines. 🌐👩‍⚕️

Publication Top Notes :

Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System)

Social Media Interventions for Patients and Public: Opportunities and Challenges for the Urology Community

Cystic Renal Lesions: A Systematic Review of Diagnosis and Treatment

Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective

Comparison of Low-Power vs High-Power Holmium Lasers in Pediatric Retrograde Intrarenal Surgery Outcomes

Voice Assistants as Consultants for Male Patients with Sexual Dysfunction: A Reliable Option?

Conservative Non-surgical Options for Erectile Dysfunction

The Intersection of Artificial Intelligence and Social Media in Shaping the New Digital Health Frontier: Powers and Perils

Correction: Peyronie’s Disease Questionnaire (PDQ): Spanish translation and validation (International Journal of Impotence Research

Functional Role of STIM-1 and Orai1 in Human Microvascular Aging